Also called: VHL
Important: This page is general information, not medical advice. It does not recommend or prescribe any treatment. Always consult your doctor or pharmacist before starting, stopping or changing any medicine.
About Von Hippel-Lindau Disease
Von Hippel-Lindau disease (VHL) is a rare disease that causes tumors and cysts to grow in your body. They can grow in your brain and spinal cord, kidneys, pancreas, adrenal glands, and reproductive tract. The tumors are usually benign (non-cancerous). But some tumors, such as those in the kidney and pancreas, can become cancerous.
VHL is a genetic disease. It is inherited, which means that it is passed down from parent to child.
Symptoms of VHL depend on the size and location of the tumors. They may include:
- Headaches
- Problems with balance and walking
- Dizziness
- Weakness of the limbs
- Vision problems
- High blood pressure
Detecting and treating VHL early is important. Your health care provider may suspect that you have VHL if you have certain patterns of cysts and tumors. There is a genetic test for VHL. If you have it, you will need other tests, including imaging tests, to look for tumors and cysts.
Treatment can vary, depending on the location and size of the tumors and cysts. It usually involves surgery. Certain tumors may be treated with radiation therapy. The goal is to treat growths while they are small and before they do permanent damage. You will need to have careful monitoring by a doctor and/or medical team familiar with the disorder.
It sits within Genetics/Birth Defects.
The lead U.S. institute for this subject is the National Institute of Neurological Disorders and Stroke.
When to speak to someone. Reading about a topic cannot tell you whether it applies to you. Speak to a doctor or pharmacist if symptoms are severe, sudden, getting worse, or simply not going away — and seek emergency care immediately for chest pain, breathing difficulty, sudden weakness or confusion, or a serious allergic reaction.
Research on Von Hippel-Lindau Disease
63 studies areregistered for this condition on ClinicalTrials.gov, the U.S. National Library of Medicine's public registry. A selection is below — the links go straight to the registry entry, not to a summary of ours.
What a registered study does and does not mean. Registration means a study exists and has been declared publicly. It says nothing about whether the treatment being tested works, is safe, or is available to you. Many studies find no benefit — that is what research is for. Never seek out an experimental treatment on the strength of a registry entry alone.
Research currently under way
- Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)Merck Sharp & Dohme LLC
- Use of Tracking Devices to Locate Abnormalities During Invasive ProceduresNational Institutes of Health Clinical Center (CC)
- Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant DisordersNational Cancer Institute (NCI)
- Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)Merck Sharp & Dohme LLC
- Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau DiseaseNational Institute of Neurological Disorders and Stroke (NINDS)
- Pediatric Von Hippel-Lindau Disease: Natural History, Predictive Factors, and Long-Term Functional Outcomes of Central Nervous System HemangioblastomasAssistance Publique - Hôpitaux de Paris
Research already completed
- Retrospective Case Series of Trans-scleral Cryotherapy for Retinal HemangioblastomaNational Eye Institute (NEI)
Study data from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. Retrieved 2026-07-30. Registry entries are supplied by study sponsors and investigators; ClinicalTrials.gov does not verify their scientific validity. PocketsInfo is not affiliated with, and not endorsed by, the NLM or the NIH.
Where to read more
Rather than paraphrase, we point you to the primary sources. Every link below is to a government health agency, a national institute or a recognised medical body — grouped by what you are trying to find out.
Learn More
- Find a Genetic CounselorNational Society of Genetic Counselors
- VHL ResourcesVHL Alliance
- Von Hippel-Lindau (VHL) SyndromeNational Institute of Neurological Disorders and Stroke
- Von Hippel-Lindau SyndromeGenetic and Rare Diseases Information Center
- What is VHL?VHL Alliance
Genetics
- Von Hippel-Lindau syndrome: MedlinePlus GeneticsNational Library of Medicine
Clinical Trials
- ClinicalTrials.gov: von Hippel-Lindau DiseaseNational Institutes of Health
Medical subject headings
Clinicians and researchers index this subject under von Hippel-Lindau Disease. These are the terms to use when searching medical literature.
This page is built from the MedlinePlus health topic record for Von Hippel-Lindau Disease, a service of the U.S. National Library of Medicine (NLM), National Institutes of Health. Information is from MedlinePlus.gov. PocketsInfo is not affiliated with, and is not endorsed by, the NLM or the NIH. Retrieved 30 July 2026.